Herasight have set a new standard in genetic prediction of Type 1 diabetes. T1D straddles the boundary between PGT-M (for single gene disorders) and PGT-P (for polygenic). There's an outsized contribution from risk alleles in the HLA region, so in families with a parent that

We’re proud of this achievement which has been almost four years in the making. Stay tuned for CogPGT 2.0, which will have more variants and more advanced methodology. Exciting times in genomics!

Herasight have developed the most powerful genetic predictor of IQ, achieving a correlation of ~0.5 with latent general cognitive ability (g). Herasight demonstrated strong predictive ability within-family, making effective embryo selection for IQ possible for the first time.

Paul Novosad Herasight Yes, your post is clearly a positive for them! This is unstoppable because the incentives are so enormous. I imagine future generations will find it surprising that we let the most important decision be taken by the genetic lottery.

Hard to overstate just what a quantum leap this is compared to anything else that came before it. A correlation of .45 within-family means you can now boost your kid's IQ by 4-10 points with embryo selection. Literally double the gain of the next closest predictor.

A million views on a post introducing our important new research. It's gratifying seeing the reach this has gotten from just my personal account. Our Herasight inbox is blowing up with interest from couples looking to screen. Very exciting! Thanks to everyone who engaged.

Today parents can, for the first time, access polygenic embryo testing for IQ and many diseases through a routine test (PGT-A) done worldwide and in 60% of US IVF cycles. Read on to learn how Herasight’s ImputePGTA algorithm is enabling polygenic testing in IVF to go global. 🧵

For example, someone in Mongolia reached out to Herasight after hearing about us on Mongolian radio. By sending us their PGT-A data along with parental saliva samples, we can provide them with advanced genetic testing of embryos previously only available in the US.

Alex Strudwick Young I am really proud of the Herasight team and excited for this new breakthrough in reprogenetics. This is a huge accomplishment which could not have been possible without Alex Strudwick Young and Jeremy's hard work.

Herasight has done it again! Now they've invented a way to take some of the most readily available data from IVF clinics and get accurate polygenic scores from it That means Herasight can help any couple do embryo selection! And they want to prove it with 90% off testing!

The timeline flip will surprise many, but embryo screening polygenic traits like IQ is going to be a mass-market consumer good extremely quickly, when it springboards on PGT-A. Many bioethicists criticized PGT-P on "accessibility" grounds that already look ridiculous.

Just to explain: Herasight can work with any PGT-A data (widely available in IVF clinics worldwide) to deliver polygenic embryo testing. No additional testing on embryos is needed, just saliva samples from parents.

Herasight is ~70% of the reason I'm optimistic about the future.

People are kind of sleeping on this, but the number of parents who can increase their kids IQ or decrease their risk of Alzheimer's just got ~50x larger almost overnight. Literally hundreds of thousands of couples can do this now.

Herasight şirketi embriyo seçimi yapmanıza olanak tanıyan bir şirket. Güncel olarak çocuğunuzun tam ölçekli IQ skorunu (FullScale IQ), alzheimer ve diyabet 2 riskini falan seçebiliyorsunuz. Daha birçok şey var. Eğer ülkenizden bunu yaptıran ilk kişiyseniz %90 indirim var. Hemen

Thrilled to see Brook Silva-Braga from CBS highlight our work!

Herasight featured on CBS Saturday Morning, including our technological breakthrough enabling polygenic embryo testing from a routine test widely available in the US and worldwide (PGT-A). Effective polygenic testing for IQ and many diseases is coming to an IVF clinic near you.